Lyme disease: Gold for Scotland and bronze for USA

Scottish Medical Journal

Volumn 48, Issue 1, 2003, Pages 6-9

  Davidson, M M ^a   Evans, R ^a   Ho Yen, Darrel O ^a  

^a RAIGMORE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; DOXYCYCLINE; ERYTHROMYCIN; LYME DISEASE VACCINE;

ARTHRITIS; BACTERIAL STRAIN; BORRELIA BURGDORFERI; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME IMMUNOASSAY; ERYTHEMA CHRONICUM MIGRANS; FUTUROLOGY; HUMAN; INFECTION PREVENTION; LABORATORY DIAGNOSIS; LYME DISEASE; NONHUMAN; NOTE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; UNITED STATES;

EID: 0037303585     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/003693300304800102     Document Type: Note

References (74)

1. Hendry G, Ho-Yen D. Tick-borne human diseases. Eds. Hendry G, Ho-Yen D. In Ticks. A lay guide to a human hazard. Edinburgh, Mercat Press, 1998, 1st edition, 35-55.
2. Shapiro ED, Gerber MA. Lyme disease. Clin Infect Dis 2000; 31: 533-542.
3. Weber K. Aspects of Lyme borreliosis in Europe. Eur J Clin Microbiol Infect Dis 2001; 20: 6-13.
4. Cutler SJ, Woodward MJ. Lyme borreliosis in the UK - ecology and risks to domestic animals and man. Rev Med Microbiol 2001; 12: 199-209.
5. Ho-Yen DO, Davidson MM, Chisholm SM, Joss AWL. How prevalent is Lyme disease in Scotland? SCIEH Weekly Report 1999;33:214-215.
6. Hercogova J and Brzonova I. Lyme disease in Central Europe. Curr Op Infect Dis 2001; 14: 133-137.
7. Nuttall P, Randolph S, Carey D, Craine N, Livesley A, Gern L. The ecology of Lyme borreliosis in the UK. Eds. Axford JS, Rees DHE. In: Lyme Borreliosis, New York, Plenum Press 1994, 125-129.
8. Hubbard MJ, Baker AS, Cann KJ. Distribution of Borrelia burgdorferi s.l. spirochaete DNA in British ticks (Argasidae and Ixodidae) since the 19th century, assessed by PCR. Med Vet Entomol 1998; 12: 89-97.
9. Ling CL, Joss AWL, Davidson MM, Ho-Yen DO. Identification of different Borrelia burgdorferi genomic groups from Scottish ticks. J Clin Pathol: Mol Pathol 2000; 53: 94-98.
10. Livesley MA, Carey D, Gern L, Nuttall PA. Problems of isolating Borrelia burgdorferi from ticks collected in United Kingdom foci of Lyme disease. Med Vet Entomol 1994; 8: 172-178.
11. Davidson MM, Evans R, Ling CL, Wiseman AD, Joss AWL, Ho-Yen DO. Isolation of Borrelia burgdorferi from ticks in the Highlands of Scotland. J Med Microbiol 1999; 48: 59-65.
12. Van Dam AP, Kuiper H, Vos K et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993; 17: 708-717.
13. Golightly MG, Benach J. Tick-borne diseases. Rev Med Microbiol 1999; 10: 1-10.
14. Steere AC. Lyme disease. N Engl J Med 2001; 345: 115-125.
15. Edlow JA. Erythema migrans. Ed. Edlow JA. In: The medical clinics of North America. Tick-borne diseases. Philadelphia, WB Saunders Co, 2002, 86, 239-260.
16. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998; 352: 557-565.
17. Pinto DS. Cardiac manifestations of Lyme disease. Ed. Edlow JA. In: The medical clinics of North America. Tick-borne diseases. Philadelphia, WB Saunders Co, 2002, 86, 285-296.
18. Cary NRB, Fox B, Wright DJM, Cutler SJ, Shapiro LM, Grace AA. Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node. Postgrad Med J 1990; 66: 134-136.
19. Coyle PK, Schutzer SE. Neurological aspects of Lyme disease. Ed. Edlow JA. In: The medical clinics of North America. Tick-borne diseases. Philadelphia, WB Saunders Co, 2002, 86, 261-284.
20. Ziska MH, Donta ST, Demarest FC. Physician preferences in the diagnosis and treatment of Lyme disease. Infection 1996; 23: 1-5.
21. Donta ST. Late and chronic Lyme disease. Ed. Edlow JA. In: The medical clinics of North America. Tick-borne diseases. Philadelphia, WB Saunders Co, 2002, 86, 341-350.
22. Stanek G, O'Connell S, Cimmino M et al. European Union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741-747.
23. Goodlad JR, Davidson MM, Hollowood K et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am J Surg Pathol 2000; 24: 1279-1285.
24. Cerroni L, Zuchling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457-461.
25. Shadick NA, Phillips CB, Logigian EL et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 1994; 121: 560-567.
26. Maraspin V, Cimperman J, Lotri-Furlan S, Pleterski-Rigler D, Strle F. Erythema migrans in pregnancy. Wien Klin Wochenschr 1999; 111: 933-940.
27. Reed KD. Laboratory testing for Lyme disease: possibilities and practicalities. J Clin Microbiol 2002; 40: 319-324.
28. Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C. Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease. J Clin Microbiol 2000; 38: 1648-1650.
29. Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C. Yield of large-volume blood cultures in patients with early Lyme disease. J Infect Dis 2001; 184: 1070-1072.
30. Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 1998; 36: 2658-2665.
31. Dumler JS. Molecular diagnosis of Lyme disease: Review and meta-analysis. Mol Diagn 2001; 6: 1-11.
32. Anonymous. Recommendations for test performance and interpretation from the 2nd national conference on serologic diagnosis of Lyme disease. MMWR: 1995; 44: 590-591.
33. Tugwell P, Dennis DT, Weinstein A et al. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997; 127: 1106-1108.
34. Hauser U, Lehnert G, Lobentanzer R, Wilske B. Interpretation criteria for standardized western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 1997; 35: 1433-1444.
35. Hauser U, Lehnert G, Wilske B. Validity of interpretation criteria for standardised western blots (Immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 1999; 37: 2241-2247.
36. Ryffel K, Puter O, Rutti B, Suard A, Dayer E. Scored antibody reactivity determined by immunoblotting shows an association between clinical manifestations and presence of Borrelia burgdorferi sensu stricto, B.garinii, B.afzelii and B.valaisiana in humans. J Clin Microbiol 1999; 37: 4086-4092.
37. Robertson J, Guy E, Andrews N et al. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 2000; 38: 2097-2102.
38. Davidson MM, Chisholm SM, Wiseman AD, Joss AWL, Ho-Yen DO. Improved serodiagnosis of Lyme disease. J Clin Pathol: Mol Pathol 1996; 49: M80-M84.
39. Gerber MA, Zemel LS, Shapiro ED. Lyme arthritis in children: clinical epidemiology and long-term outcomes. Paediatrics 1998;102:905-908.
40. Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC. Evaluation of study patients with Lyme disease, 10-20 year follow-up. J Infect Dis 2001; 183: 453-460.
41. Berglund J. Natural history and long-term consequences of Lyme disease in children. Curr Op Infect Dis 1999; 12: 265-269.
42. Wormser GP, Nadelman RB, Dattwyler RJ et al. Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 2000; 31(Suppl 1): S1-S14.
43. Dovetall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease - associated facial palsy and meningitis. Clin Infect Dis 1999; 28: 569-574.
44. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 1998; 128: 354-362.
45. Barbour AG. Expert advice and patient expectations. Laboratory testing and antibiotics for Lyme disease. J Am Med Assoc 1998; 279: 239-240.
46. Fix AD, Strickland GT, Grant J. Tick bites and Lyme disease in an endemic setting. Problematic use of serologic testing and prophylactic antibiotic therapy. J Am Med Assoc 1998; 279: 206-210.
47. Robertson JN, Gray JS, Stewart P. Tick bite and Lyme borreliosis risk at a recreational site in England. Eur J Epidemiol 2000; 16: 647-652.
48. Pontrelli L, Dattwyler R, Nachman S. Single dose doxycycline for the prevention of Lyme disease. N Engl J Med 2001; 345: 1348.
49. Hendry G, Ho-Yen D. Know your enemy. Eds Hendry G, Ho-Yen D. In Ticks. A lay guide to a human hazard. Edinburgh, Mercat Press, 1998, 1st edition, 12-24.
50. Guy EC, Farquhar RG. Borrelia burgdorferi in urban parks. Lancet 1991; 338: 253.
51. Hendry G, Ho-Yen D. Control of ticks on humans. Eds Hendry G, Ho-Yen D. In Ticks. A lay guide to a human hazard. Edinburgh, Mercat Press, 1998, 1st edition, 66-76.
52. Dennis DT, Hayes EB, Orloski KA, Meltzer MI. Recommendations for the use of Lyme disease vaccine. MMWR 1999; 48: 1-25.
53. Thanassi WT, Schoen RT. The Lyme disease vaccine: conception, development, and implementation. Ann Intern Med 2000; 132: 661-668.
54. Hsia EC, Chung JB, Schwartz JS, Albert DA. Cost-effectiveness analysis of the Lyme disease vaccine. Arthritis Rheum 2002; 46: 1651-1660.
55. Luft BJ, Dunn JJ, Lawson CL. Approaches towards the directed design of a vaccine against Borrelia burgdorferi. J Infect Dis 2002; 185(Suppl 1): S46-S51.
56. www2.lymenet.org/domino/file.nsf/uid/guidelines
57. www.fairfieldweekly.com/articles/lymedisease.html
58. www.niaid.nih.gov/publications/ticks.htm
59. Rowe PM. Chronic Lyme disease: the debate goes on. Lancet 2000; 355: 1436.
60. Klempner MS, Hu LT, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345: 85-92.
61. Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM. Death from inappropriate therapy for Lyme disease. Clin Infect Dis 2000; 31: 1107-1109.
62. Molloy PJ, Persing DH, Berardi VP. False positive results of PCR testing for Lyme disease. Clin Infect Dis 2001; 33: 412-413.
63. Hul§nsk D, VotΩpka J, Valesov M. Persistence of Borrelia garinii and Borrelia afzelii in patients with Lyme arthritis. Zent bl Bakteriol 1999; 289: 301-318.
64. Limbach F-X, Jaulhac B, Puechal X et al. Treatment resistant Lyme arthritis caused by Borrelia garinii. Ann Rheum Dis 200;60:284-286.
65. Burkert S, Russler D, Munchhofuf P, Wilske B. Development of enzyme-linked immunosorbent assays using recombinant borrelial antigens for serodiagnosis of Borrelia burgdorferi infection. Med Microbiol Immunol 1996; 185: 49-57.
66. Kaiser R, Rauer S. Advantage of recombinant borrelial proteins for serodiagnosis of neuroborreliosis. J Med Microbiol 1999; 48: 5-10.
67. Magnarelli LA, Fikrig E, Padula SJ, Anderson JF, Flavell RA. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol 1996; 34: 237-240.
68. Lawrenz MB, Hardham JM, Owens RT et al. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol 1999; 37: 3997-4004.
69. Brunner M, Stein S, Mitchell PD, Sigal LH. Immunoglobulin M capture assay for serologic confirmation of early Lyme disease: analysis of immune complexes with biotinylated Borrelia burgdorferi sonicate enhanced with flagellin peptide epitope. J Clin Microbiol 1998; 36: 1074-1080.
70. Brunner M, Sigal LH. Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi. J Clin Microbiol 2001; 39: 3213-3221.
71. Burgdorfer W. Arthropod-borne spirochetoses: a historical perspective. Eur J Clin Microbiol Infect Dis 2001; 20: 1-5.
72. Phillips SE, Mattman LH, Hulinska D, Moayad H. A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated. Infection 1998; 26: 348-367.
73. Nowakowski J, Schwartz I, Liveris D et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis 2001; 33: 2023-2027.
74. Curtin SM, Pennington TH. Borrelia burgdorferi studies in man and ticks in Scotland. Eds. Axford JS, Rees DHE. In: Lyme Borreliosis New York, Plenum Press 1994: 147-154.